Barclays PLC Akoya Biosciences, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Barclays PLC holds 43,481 shares of AKYA stock, worth $89,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,481

Previous 39,472 10.16%

Holding current value

$89,136

Previous $107,000 7.48%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$2.07 - $3.24 $8,298 - $12,989	4,009 Added 10.16%	43,481 $99,000
Q3 2024 Nov 15, 2024	BUY	$1.96 - $2.94 $58,986 - $88,479	30,095 Added 320.94%	39,472 $107,000
Q2 2024 Aug 14, 2024	SELL	$1.94 - $4.56 $16,588 - $38,992	-8,551 Reduced 47.7%	9,377 $21,000
Q1 2024 May 15, 2024	SELL	$4.33 - $6.06 $66,963 - $93,717	-15,465 Reduced 46.31%	17,928 $84,000
Q4 2023 Feb 15, 2024	BUY	$3.13 - $5.13 $87,445 - $143,321	27,938 Added 512.15%	33,393 $163,000
Q3 2023 Nov 07, 2023	BUY	$4.24 - $7.44 $7,801 - $13,689	1,840 Added 50.9%	5,455 $26,000
Q2 2023 Aug 03, 2023	SELL	$5.28 - $8.35 $23,041 - $36,439	-4,364 Reduced 54.69%	3,615 $27,000
Q1 2023 May 04, 2023	BUY	$7.6 - $12.68 $28,454 - $47,473	3,744 Added 88.41%	7,979 $65,000
Q4 2022 Feb 13, 2023	BUY	$8.6 - $14.1 $30,667 - $50,280	3,566 Added 533.03%	4,235 $40,000
Q3 2022 Nov 03, 2022	SELL	$10.63 - $15.76 $63,588 - $94,276	-5,982 Reduced 89.94%	669 $8,000
Q2 2022 Aug 12, 2022	SELL	$8.38 - $12.85 $11,623 - $17,822	-1,387 Reduced 17.26%	6,651 $85,000
Q1 2022 May 16, 2022	BUY	$9.84 - $14.97 $79,093 - $120,328	8,038 New	8,038 $88,000

Others Institutions Holding AKYA

# of Institutions

Shares Held

11.9M

Call Options Held

40.5K

Put Options Held

View Full List

About Akoya Biosciences, Inc.

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $77.7M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

More about AKYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account